Search
BIOMED Home >> | Who We Are | Faculty | Research | Undergraduate Program | Graduate Programs | Students | Alumni  | Contact Us

Print friendly version of this event. Mail this event to a friend.

CURRENT EVENTS...

Master's Thesis Defense - Micro-grooved Surface Topography Does Not Influence Fretting Corrosion of Tapers in THA: Classification and Retrieval Analysis

Master's Thesis Defense - Conversion of Murine Embryonic Stem Cells to Neural Precursor Cells, Astrocytes and Neurons by Differentiation and Corticogenesis and Its Characterization

Master's Thesis Defense - Development of Ultrasound-Triggered Antibiotic Release Clip to Prevent Spinal Fusion Infection

Seminar - Nanomechanics of Murine Synovial Joint Tissues: A Novel Interdisciplinary Approach to Uncover the Pathogenesis of Osteoarthritis

Ph.D. Thesis Defense - Interaction of Non-Thermal, Non-Cavitational 20-100 KHz Ultrasound and Biological Tissue: Modeling, Experimental Validation, and Clinical Implications

Master's Thesis Defense - Augmentation of a Knit Structure with Increased Suture Retention and Poly Glycerol Sebacate Coating for Rotator Cuff Repair Graft Applications


EVENTS Archive
EVENT GALLERY Archive
NEWS & EVENTS Home
BIOMED Home
Seminar - Rationale for the Use of Antipsychotic Medications in Autism
Date: April 25, 2008
Time: 4:00 PM
Location: Matheson Hall, Room: 109

Speaker(s):
Richard P. Malone, M.D.
Professor of Psychiatry
Drexel University College of Medicine

Details:
Autistic disorder is a serious childhood-onset disorder that affects all areas of development, particularly in the areas of language, communication, and reciprocal social interaction. Patients with autistic disorder typically demonstrate repetitiveness and a restricted repertoire of behavior. Additionally, they also have a number of disruptive symptoms that may be reduced by drug treatment including severe tantrums, hyperactivity and lability. The antipsychotic drugs are the drugs that are the most critically studied as treatments for reducing symptoms. Both the first generation and second generation antipsychotic drugs have shown safety and efficacy in short and long-term studies in autism. The most studied antipsychotic drugs include haloperidol and risperidone, though studies of other antipsychotic drugs are underway. Safety concerns associated with treatment include the risk of drug-related dyskinesias, which is greater with the first generation drugs, and the risk of weight gain and associated metabolic problems (i.e., increases in glucose and lipids), which is greater with second generation agents. Prescription of antipsychotic drugs requires careful monitoring because of these safety risks.

To attend the webcast, please visit:
WATCH WEBCAST

Biosketch:

Directions:
Matheson Hall is located at 32nd and Market Streets.

Phone 215.895.2215 | Fax 215.895.4983 | Email biomed@drexel.edu
Copyright 2015, Drexel University, All Rights Reserved.